Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort

This publication has 41 references indexed in Scilit:

• Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
  Current Opinion in Lipidology, 2001
• VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial
  Circulation, 2000
• Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France
  Atherosclerosis, 2000
• Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment
  Atherosclerosis, 2000
• Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia
  Mineral and Electrolyte Metabolism, 1999
• Atherogenicity of Triglyceride-Rich Lipoproteins
  The American Journal of Cardiology, 1998
• Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity
  Gastroenterology, 1996
• [2] Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins
  Published by Elsevier ,1996
• Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: Reference values, and age- and sex-related differences
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1991
• Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
  Science, 1990